| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.27 | 1e-07 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.24 | 1e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.25 | 1e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.29 | 2e-06 |